Phase II Clinical Trial of NEPA (Netupitant/Palonosetron) for Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patient Receiving the BEAM Conditioning Regimen

被引：0
|
作者：
Bubalo, Joseph [1 ]
Chen, Andy I. [2 ]
Leong, Kelli [3 ]
Gille, Bianca [4 ]
Nagle, Sarah [5 ]
Bensch, Kenneth [4 ]
Macey, Tara [4 ]
Ellison, Kelly [4 ]
Booth, Georgeann [4 ]
Misra, Shikha [4 ]
Maziarz, Richard T. [6 ]
机构：
[1] Oregon Hlth & Sci Univ Hosp, Pharm Serv, CR 9-4, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Hematol Malignancies, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ Hosp, Pharm, Portland, OR USA
[4] Oregon Hlth & Sci Univ Hosp, Portland, OR USA
[5] Oregon Hlth & Sci Univ Hosp, Portland, PA USA
[6] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
414
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Assessing the benefit of NEPA (fixed combination of netupitant/palonosetron) for preventing chemotherapy-induced nausea and vomiting (CINV) in patients at increased emetic risk receiving moderately emetogenic chemotherapy
    Molasiotis, A.
    Aapro, M. S.
    Alonzi, A.
    Chrapava, M.
    Jordan, K.
    Roeland, E. J.
    Schwartzberg, L. S.
    Terrasanta, C.
    Olivari, S.
    Dranitsaris, G.
    ANNALS OF ONCOLOGY, 2022, 33 : 1546 - 1546
  • [22] Efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy (MEC)
    Aapro, M.
    Rossi, G.
    Rizzi, G.
    Borroni, M. E.
    Lorusso, V.
    Karthaus, M.
    Grunberg, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S266 - S266
  • [23] Assessing the Benefit of NEPA (Fixed Combination of Netupitant/Palonosetron) for preventing Chemotherapy-induced Nausea and Vomiting (CINV) in patients at increased emetic risk receiving moderately emetogenic chemotherapy
    Karthaus, M.
    Christoph, D. C.
    Lux, M. P.
    Hofheinz, R. -D
    Jordan, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 252 - 253
  • [24] Budget impact of netupitant/palonosetron for the prevention of chemotherapy-induced nausea and vomiting
    Park, Sang Hee
    Binder, Gary
    Corman, Shelby
    Botteman, Marc
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (08) : 840 - 847
  • [25] A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
    Zhang, L.
    Lu, S.
    Feng, J.
    Dechaphunkul, A.
    Chang, J.
    Wang, D.
    Chessari, S.
    Lanzarotti, C.
    Jordan, K.
    Aapro, M.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 452 - 458
  • [26] Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study
    Chang, Jianhua
    Chen, Gongyan
    Wang, Dong
    Wang, Guihua
    Lu, Shun
    Feng, Jifeng
    Li, Wei
    Li, Ping
    Lanzarotti, Corinna
    Chessari, Salvatore
    Zhang, Li
    CANCER MEDICINE, 2020, 9 (14): : 5134 - 5142
  • [27] ONE DAY ANTIEMETIC PROPHYLAXIS WITH NEPA (NETUPITANT/PALONOSETRON) AND DEXAMETHASONE TO PREVENT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN HODGKIN'S LYMPHOMA NAIVE PATIENTS RECEIVING ABVD REGIMEN: A MULTICENTER PHASE IIA STUDY
    Cantonetti, M.
    Bolis, S. A. M.
    Abruzzese, E.
    Bosi, A.
    Patti, C.
    Di Renzo, N.
    Flenghi, L.
    Stelitano, C.
    Mannina, D.
    Sassone, M.
    De Stefano, A.
    Chiaramonte, C.
    Tesei, C.
    Provenzano, I.
    Nasso, D.
    HAEMATOLOGICA, 2020, 105 : S103 - S103
  • [28] Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice
    Aapro, Matti
    Jordan, Karin
    Scotte, Florian
    Celio, Luigi
    Karthaus, Meinolf
    Roeland, Eric
    CURRENT CANCER DRUG TARGETS, 2022, 22 (10) : 806 - 824
  • [29] Netupitant and palonosetron (NEPA): a winning team in the race for the optimal treatment of chemotherapy-induced nausea and vomiting?
    Andrews, P. L. R.
    ANNALS OF ONCOLOGY, 2014, 25 (07) : 1258 - 1259
  • [30] Retrospective Evaluation of a Dexamethasone Sparing Antiemetic Regimen: An Antiemetic Prophylaxis Study on NEPA (Netupitant Plus Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients
    Agre, Suhas
    Agre, Madhura
    Pol, Pooja
    Tonse, Mubarakunnisa
    Mohanty, Mitasha
    Shaikh, Alfiya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
12345